Searching for Solutions
AAPP 2025 Outcomes Grant Award Application Portal is OPEN

AAPP has committed up to $250,000 to support a project that will generate a high-quality, large sample size (n) data set that evaluates the impact of integrating psychiatric pharmacists into team-based mental health care in a study with multiple research sites and investigators. Download the RFP and submit your application by the Oct. 1, 2025, deadline.
AAPP 2025 Practice Expansion Grant Application Portal is OPEN

Two $25,000 grants are available to support quality improvement projects that support the integration of psychiatric pharmacists into mental health care teams. Projects like these are critical for the advancement of the psychiatric pharmacy profession. Download the RFP and submit your application by the Oct. 1, 2025, deadline.
HHS Announces $100M in Pilot Funding Opportunity to Eliminate Hepatitis C

HHS announced a $100M pilot funding opportunity to prevent, test for, treat and cure Hepatitis C (HCV) in individuals with substance use disorder (SUD) and/or Serious Mental Illness (SMI). This program is particularly designed to support communities severely affected by homelessness and to gain insights on effective ways to identify patients, complete treatment, cure infections, and reduce reinfection by Hepatitis C (a liver disease caused by the Hepatitis C virus).
SAMHSA Releases Annual National Survey on Drug Use and Health

The Substance Abuse and Mental Health Services Administration (SAMHSA) released the results of the 2024 National Survey on Drug Use and Health (NSDUH), which shows how people living in the United States reported their experiences with mental health conditions, substance use and pursuit of treatment. This year marks the first year since 2020 in which there are at least four years of comparable data for key NSDUH outcomes to enable reporting of trends.
SUD Scoop Series

Each 30-minute webinar offers a dynamic, peer-driven discussion focused on complex substance use disorder cases. Free to AAPP members! Click the link to learn more and register.
Updated Clozapine Toolkit Now Available!

The Clozapine in Practice toolkit has recently been updated to reflect the discontinuation of the REMS and to describe current information on monitoring guidelines. A special thanks to lead author Jonathan Leung and co-authors Robin Hieber, Jenna Stearns, and Greg Deardorff for their work to update this important toolkit.